Recombinant SUMO protease
Others
Formulation:
Source:
E. coli
Usage:
For Research Use Only
Recombinant SUMO protease
The product is for non-human research only. Not for therapeutic or veterinary use.
Catalog Number: BT-224151
Formulation: total activity >500U in 50% glycerol, 75 mM Tris pH 8.0,150 mM NaCl, 0.5 mM DTT and 1 mM EDTA
Source: E. coli
| Product Name | Recombinant SUMO protease |
|---|---|
| Application | SUMO proteins are a family of small proteins covalently attached to other proteins in cells to modify their function. SUMOylation is a post-translational modification involved in many cellular processes.SUMO protease detaches SUMO from a SUMOylated protein |
| Formulation | total activity >500U in 50% glycerol, 75 mM Tris pH 8.0,150 mM NaCl, 0.5 mM DTT and 1 mM EDTA |
| Product Background | Small ubiquitin-like modifier (SUMO) is commonly used as a protein fusion domain to facilitate expression and purification of recombinant proteins, and a SUMO-specific protease is then used to remove SUMO from these proteins. SUMO proteases catalyze two reactions, deconjugation of SUMO from substrates and processing of precursor SUMO isoforms to prepare SUMO for conjugation. The SUMO protease family includes two members in yeast (Ulp1 and Ulp2) and as many as six members in human (SENP1–3, SENP5–7). SENP/Ulp proteases each contain conserved C-terminal domains that catalyze protease activity. The C-terminal protease domains exhibit unique specificities during SUMO processing and deconjugation in vitro. |
| Product Memo | SUMO protease Recombinant |
| Product Type | Enzyme |
| Source | E. coli |
| Storage | Store the SUMO protease at -20℃ |
| Usage | For Research Use Only |
| Last Modified | Jul 26 2021 |